We could show that INHBA negatively correlates with CD8+ T cells in OPSCC primary tumors, which concurs with the findings by Pinjusic and colleagues demonstrating the indirect ability of INHBA to reduce CD8+ T cells tumor infiltration in melanoma in vivo models by downregulating the production of CXCL9/10 (38). The gene discussed is CD8A; the disease is melanoma.